Protein kinase C isozyme-specific modulation of cyclic AMP-dependent phosphodiesterase in hypertrophic cardiomyopathic hamster hearts
Related Experiment Video
Updated: Oct 14, 2026

Isolation, Culture, and Functional Characterization of Adult Mouse Cardiomyoctyes
Published on: September 24, 2013
1Department of Internal Medicine, University of Iowa College of Medicine, Iowa City 52242, USA.
Insights
Protein kinase C (PKC) isozymes, particularly PKC alpha, are elevated in hypertrophic cardiomyopathy (HCM) hearts. This PKC alpha isozyme specifically mediates the interaction between PKC and phosphodiesterase (PDE) in HCM.
Area of Science:
- Cardiology
- Molecular Biology
- Biochemistry
Background:
- Protein kinase C (PKC) activity is elevated in hypertrophic cardiomyopathic (HCM) hamster hearts.
- PKC activation stimulates cAMP-dependent phosphodiesterase (PDE) activity in HCM.
Purpose of the Study:
- To determine the composition of PKC isozymes in control and HCM hearts.
- To identify the specific PKC isozyme responsible for modulating PDE activity in HCM hearts.
Main Methods:
- Quantitative autoradiographic techniques with isozyme-specific antibodies.
- Measurement of PKC enzymatic activity in membrane and cytosol fractions.
- Immunoprecipitation assays to assess individual PKC isozyme contributions.
Main Results:
- PKC alpha, epsilon, and zeta isozymes are expressed in both control and HCM hearts.
- Elevated levels of specific PKC isozymes (cytosolic PKC alpha and epsilon, membrane PKC zeta) were observed in HCM hearts.
- PKC alpha, but not epsilon or zeta, was identified as the specific isozyme mediating PKC-enhanced PDE activity in HCM.
Conclusions:
- Hypertrophic cardiomyopathy is characterized by increased quantitative expression of specific PKC isozymes.
- The cross-talk between PKC and PDE in HCM hearts is specifically mediated by the PKC alpha isozyme.
Abstract:
We recently demonstrated that protein kinase C (PKC) activities were elevated in hypertrophic cardiomyopathic (HCM) hamster hearts and that activation of PKC resulted in stimulation of cAMP-dependent phosphodiesterase (PDE) activity. In this study, we determined the composition of PKC isozymes in control and HCM hearts and identified the PKC isozyme responsible for the modulation of PDE activity in HCM hearts. Using quantitative autoradiographic techniques with PKC isozyme-specific antibodies, we found that the PKC alpha, epsilon, and zeta isozymes were expressed in both control and HCM hearts. The immunoreactive amounts of cytosolic PKC alpha and PKC epsilon and of membrane PKC zeta were significantly increased in HCM hearts. The enzymatic activity of PKC in HCM hearts was significantly elevated in both membrane (148.0 +/- 13.7 versus 78.9 +/- 1.9 pmol/mg/min in controls, four experiments) and cytosol (117.3 +/- 5.1 versus 75.7 +/- 5.1 pmol/mg/min in controls, four experiments). Contribution of individual PKC isozyme activity was assessed by the immunoprecipitable PKC activity with isozyme-specific antibodies. The membrane PKC epsilon (41.7 +/- 4.9 versus 18.7 +/- 0.3 pmol/mg/min in controls, four experiments, p < 0.05) and PKC zeta (61.5 +/- 14.0 versus 20.3 +/- 2.7 pmol/mg/min in controls, four experiments, p < 0.05) but not PKC alpha (50.9 +/- 6.8 versus 44.3 +/- 1.5 pmol/mg/min, four experiments, p = N.S.) were increased in HCM hearts. On the other hand, the cytosolic PKC alpha (47.7 +/- 4.1 versus 27.0 +/- 1.4 pmol/mg/min, four experiments, p < 0.05) and PKC epsilon (42.8 +/- 3.1 versus 19.1 +/- 3.9 pmol/mg/min, four experiments, p < 0.05) but not PKC zeta (27.2 +/- 3.0 versus 32.0 +/- 2.1, four experiments, p = N.S.) were increased in HCM hearts. Furthermore, after immunoprecipitation of PKC alpha, activation of PKC could no longer potentiate the PDE activity in HCM hearts. Removal of PKC epsilon or PKC zeta, on the other hand, did not affect the PKC-mediated PDE stimulation in HCM hearts. These results suggest that there is an increase in the quantitative expression of PKC isozymes in HCM hearts and that the cross-talk between PKC and PDE in these hearts is mediated specifically via the PKC alpha isozyme.
Related Concept Videos
G-Protein Gated Ion Channels
Sensory organs,...
GPCRs Regulate Adenylyl Cylase Activity
Two...
cAMP-dependent Protein Kinase Pathways
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Cardiomyopathy III: Hypertrophic Cardiomyopathy

